Lifshitz Law PLLC Announces Investigations of Bath and Body Works, Inc. (NYSE: BBWI), Ardent Health, Inc. (NYSE: ARDT), Varonis Systems, Inc. (NASDAQ: VRNS), and Fermi Inc. (NASDAQ: FRMI)

NEW YORK CITY, NY / ACCESS Newswire / April 21, 2026 / Lifshitz Law Firm

Bath and Body Works, Inc. (NYSE:BBWI)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) the Company's strategy of pursuing "adjacencies, collaborations and promotions" was not growing the customer base and/or delivering the level of growth in net sales touted; (ii) as the Company's strategy of "adjacencies, collaborations and promotions" faltered, the Company relied on brand collaborations "to carry quarters" and obfuscate otherwise weak underlying financial results; (iii) as a result, the Company was unlikely to meet its own previously issued financial guidance; and (iv) that, as a result of the foregoing, the Company's positive statements about Bath and Body Works's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you are a BBWI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Ardent Health, Inc. (NYSE:ARDT)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Ardent Health's third quarter 2025 revenue was overstated due to inadequate determinations of accounts receivable collectability following the Company's transition to a new revenue accounting system and "recently completed hindsight evaluations of historical collection trends"; (ii) the Company's 2025 EBITDA guidance was overstated and would be reduced by $57.5 million at the midpoint, or approximately 9.6%, due to "persistent industry-wide cost pressures," including "payer denials"; and (iii) as a result, the Company's statements about Ardent Health's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you are an ARDT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Varonis Systems, Inc. (NASDAQ:VRNS)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Varonis's ability to convert its existing customer base; (ii) notably, that it was not truly equipped to convince existing users of the benefits of converting to the SaaS offering or otherwise maintain those customers on its platform, resulting in significantly reduced ARR growth potential in the near-term; and (iii) such statements absent these material facts caused shareholders to purchase Varonis's securities at artificially inflated prices.

If you are a VRNS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Fermi Inc. (NASDAQ:FRMI)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) the Company overstated its tenant demand for its Project Matador campus; (ii) the extent to which Project Matador would rely on a single tenant's funding commitment to finance the construction of Project Matador; (iii) there was a significant risk that that tenant would terminate its funding commitment; and (iv) as a result of the foregoing, the Company's positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you are an FRMI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING.© 2026 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.

Lifshitz Law PLLC

Phone: 516-493-9780

Facsimile: 516-280-7376

Email: [email protected]

SOURCE: Lifshitz Law Firm